Paper36925686
Rational design of a genome-based insulated system in Escherichia coli facilitates heterologous uricase expression for hyperuricemia treatment.
He L and 9 others. Bioeng Transl Med, 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Rational design of a genome-based insulated system in Escherichia coli facilitates heterologous uricase expression for hyperuricemia treatment. Papers, record 36925686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36925686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rational design of a genome-based insulated system in Escherichia coli facilitates heterologous uricase expression for hyperuricemia treatment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33798500 | Gout. | Lancet | 2021 | https://conductscience.org/library/papers/33798500 | PubMed |
| 2 | 28729031 | Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders. | Kidney Int | 2018 | https://conductscience.org/library/papers/28729031 | PubMed |
| 3 | 32812710 | Precision design of stable genetic circuits carried in highly-insulated E. coli genomic landing pads. | Mol Syst Biol | 2020 | https://conductscience.org/library/papers/32812710 | PubMed |
| 4 | 30926240 | Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut. | Cell Host Microbe | 2019 | https://conductscience.org/library/papers/30926240 | PubMed |
| 5 | 32887946 | Gut microbiota in human metabolic health and disease. | Nat Rev Microbiol | 2021 | https://conductscience.org/library/papers/32887946 | PubMed |
| 6 | 19692116 | Gout. | Lancet | 2010 | https://conductscience.org/library/papers/19692116 | PubMed |
| 7 | 30546062 | Prevention and treatment of gout. | Nat Rev Rheumatol | 2019 | https://conductscience.org/library/papers/30546062 | PubMed |
| 8 | 29555994 | Extensive impact of non-antibiotic drugs on human gut bacteria. | Nature | 2018 | https://conductscience.org/library/papers/29555994 | PubMed |
| 9 | 34968071 | Self-Cascade Uricase/Catalase Mimics Alleviate Acute Gout. | Nano Lett | 2022 | https://conductscience.org/library/papers/34968071 | PubMed |
| 10 | 30283432 | Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats. | Front Microbiol | 2018 | https://conductscience.org/library/papers/30283432 | PubMed |
| 11 | 33648977 | Hyperuricemia causes kidney damage by promoting autophagy and NLRP3-mediated inflammation in rats with urate oxidase deficiency. | Dis Model Mech | 2021 | https://conductscience.org/library/papers/33648977 | PubMed |
| 12 | 17935691 | Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane--distinct translocases and mechanisms. | Biochim Biophys Acta | 2008 | https://conductscience.org/library/papers/17935691 | PubMed |
| 13 | 2594778 | Urate oxidase: primary structure and evolutionary implications. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2594778 | PubMed |
| 14 | 4979099 | Degradation of uric acid by certain aerobic bacteria. | J Bacteriol | 1968 | https://conductscience.org/library/papers/4979099 | PubMed |
| 15 | 22437829 | Substrate selectivity of YgfU, a uric acid transporter from Escherichia coli. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22437829 | PubMed |
| 16 | 30629913 | Commensal Enterobacteriaceae Protect against Salmonella Colonization through Oxygen Competition. | Cell Host Microbe | 2019 | https://conductscience.org/library/papers/30629913 | PubMed |
| 17 | 30188536 | Live bacterial biotherapeutics in the clinic. | Nat Biotechnol | 2018 | https://conductscience.org/library/papers/30188536 | PubMed |
| 18 | 33980483 | Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches. | Sci Adv | 2021 | https://conductscience.org/library/papers/33980483 | PubMed |
| 19 | 32329387 | Recent approaches to gout drug discovery: an update. | Expert Opin Drug Discov | 2020 | https://conductscience.org/library/papers/32329387 | PubMed |
| 20 | 31822862 | Asymptomatic hyperuricaemia: a silent activator of the innate immune system. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/31822862 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978372 | Reprogramming Native Cryptic Plasmids Enables Antibiotic-Selection-Free Urate Degradation by Escherichia coli Nissle 1917. | Microb Biotechnol | 2026 | https://conductscience.org/library/papers/42978372 | PubMed |
| 42630962 | Gut microbiota dysbiosis and joint diseases: advances in the gut-joint axis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42630962 | PubMed |
| 42506417 | Bile Acid Metabolism in Gout Pathogenesis from Gut-Liver-Joint Crosstalk to Therapeutic Opportunities. | Metabolites | 2026 | https://conductscience.org/library/papers/42506417 | PubMed |
| 42415877 | Biomaterial-Based Strategies for Gout Therapy: Recent Advances, Current Challenges, and Future Perspectives - A Review. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42415877 | PubMed |
| 42029038 | Enhancing immune protection in dairy cattle: role of Escherichia coli Nissle 1917 in boosting the efficacy of a Mycoplasma bovis-BoAHV-1 combined vaccine. | mSphere | 2026 | https://conductscience.org/library/papers/42029038 | PubMed |
| 41038159 | Designer probiotic-based living drugs for uric acid homeostasis control in hyperuricemic mice and rats. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/41038159 | PubMed |
| 40340401 | Systematic Engineering for Efficient Uric Acid-Degrading Activity in Probiotic Yeast Saccharomyces boulardii. | ACS Synth Biol | 2025 | https://conductscience.org/library/papers/40340401 | PubMed |
| 40212846 | Multi-omics assessment of gut microbiota in circadian rhythm disorders: a cross-sectional clinical study. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40212846 | PubMed |
| 39595167 | Uricase-Expressing Engineered Macrophages Alleviate Murine Hyperuricemia. | Biomedicines | 2024 | https://conductscience.org/library/papers/39595167 | PubMed |
| 39122688 | Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice. | Nat Commun | 2024 | https://conductscience.org/library/papers/39122688 | PubMed |
| 38300741 | Exploring substrate-microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions. | Gut Microbes | 2024 | https://conductscience.org/library/papers/38300741 | PubMed |
| 36925686 | Rational design of a genome-based insulated system in Escherichia coli facilitates heterologous uricase expression for hyperuricemia treatment. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36925686 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCG2 | 9429 | PubTator's text mining | https://conductscience.org/library/genes/9429 | NCBI Gene |
| SLC22A12 | 116085 | PubTator's text mining | https://conductscience.org/library/genes/116085 | NCBI Gene |
| SLC2A9 | 56606 | PubTator's text mining | https://conductscience.org/library/genes/56606 | NCBI Gene |
| UOX | 391051 | PubTator's text mining | https://conductscience.org/library/genes/391051 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36925686
GET https://conductscience.org/api/papers/v1/36925686/references?page=2